Outcomes after extracorporeal membrane oxygenation support in COVID-19 and non-COVID-19 patients.
Chitaru KuriharaAdwaiy ManerikarCatherine Aiyuan GaoSatoshi WatanabeViswajit KandulaAlexandra KlonisVanessa HoppnerAzad KarimMark SaineDavid D OdellKalvin LungRafael Garza-CastillonSamuel S KimJames McCauley WalterRichard G WunderinkG R Scott BudingerAnkit BharatPublished in: Artificial organs (2021)
These findings suggest that COVID-19-associated ARDS was not associated with a higher post-ECMO mortality than non-COVID-19-associated ARDS patients, despite longer duration of extracorporeal support. Early initiation of V-V ECMO is important for improved ECMO outcomes in COVID-19 ARDS patients. Since late initiation of ECMO was associated with extremely high mortality related to lack of pulmonary recovery, it should be used judiciously or as a bridge to lung transplantation.
Keyphrases
- extracorporeal membrane oxygenation
- acute respiratory distress syndrome
- sars cov
- coronavirus disease
- respiratory failure
- mechanical ventilation
- end stage renal disease
- ejection fraction
- newly diagnosed
- metabolic syndrome
- type diabetes
- patient reported outcomes
- intensive care unit
- cardiovascular events
- cardiovascular disease
- respiratory syndrome coronavirus
- risk factors
- coronary artery disease
- insulin resistance